Addus HomeCare Q2 adjusted EPS beats estimates

Addus HomeCare

04/08/2025 21:43

Overview

Addus Q2 net service rev grows 21.8% yr/yr to $349.4 mln

Adjusted EPS for Q2 beats analyst expectations, per LSEG data

Co acquires Helping Hands Home Care to expand Pennsylvania operations

Outlook

Addus sees robust demand for home-based care services

Company plans to capitalize on growth opportunities in key markets

Company maintains conservative balance sheet to support future acquisitions

Result Drivers

ORGANIC GROWTH - Personal care segment saw 7.4% organic revenue growth, aided by state rate increases and strong hiring trends

ACQUISITION IMPACT - Revenue growth includes contributions from acquired Gentiva operations

HOSPICE SEGMENT - Hospice care segment delivered 10% organic revenue growth, driven by higher average daily census and revenue per patient day

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Adjusted EPS
Beat
$1.49
$1.47 (11 Analysts)
Q2 Adjusted Net Income
Beat
$27.30 mln
$26.50 mln (10 Analysts)
Q2 Net Income
$22.10 mln
Q2 Adjusted EBITDA
Beat
$43.90 mln
$43.10 mln (11 Analysts)
Q2 Operating Cash Flow
$22.50 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Addus Homecare Corp is $140.00, about 25% above its August 1 closing price of $104.96

The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nBw7X3vDpa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)